Spontaneous and Induced Nontransgenic Animal Models of AD: Modeling AD Using Combinatorial Approach

被引:14
|
作者
Kaushal, Alka [1 ]
Wani, Willayat Yousuf [1 ]
Anand, R. [1 ]
Gill, Kiran Dip [1 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Biochem, Chandigarh 160012, India
关键词
Alzheimer's disease; nontransgenic; animal models; amyloid beta; neurofibrillary tangles; SPORADIC ALZHEIMERS-DISEASE; AMYLOID-BETA-PEPTIDE; NEUROFIBRILLARY TANGLES; OXIDATIVE STRESS; CEREBRAL-CORTEX; SENILE PLAQUES; TAU-HYPERPHOSPHORYLATION; IBOTENIC ACID; OKADAIC-ACID; COGNITIVE DECLINE;
D O I
10.1177/1533317513488914
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Alzheimer's disease (AD), the most common neurodegenerative and dementing disorder, is characterized by extracellular amyloid deposition, intracellular neurofibrillary tangle formation, and neuronal loss. We are still behind in AD research in terms of knowledge regarding understanding its pathophysiology and designing therapeutics because of the lack of an accurate animal model for AD. A complete animal model of AD should imitate all the cognitive, behavioral, and neuropathological features of the disease. Partial models are currently in use, which only mimic specific and not all of the components of AD pathology. Currently the transgenic animals are the popular models for AD research, but different genetic backgrounds of these transgenic animals remain a major confounding factor. This review attempts to summarize the current literature on nontransgenic animal models of AD and to highlight the potential of exploiting spontaneous and induced animal models for neuropathological, neurochemical, neurobehavioral, and neuroprotective studies of AD.
引用
收藏
页码:318 / 326
页数:9
相关论文
共 50 条
  • [1] Animal models of AD
    Ashe, KH
    NEUROBIOLOGY OF AGING, 2004, 25 : S66 - S66
  • [2] The need for better AD animal models
    Medina, Miguel
    Avila, Jesus
    FRONTIERS IN PHARMACOLOGY, 2014, 5
  • [3] ANIMAL MODELS FOR PRECLINICAL TESTING OF EARLY AD?
    Windisch, Manfred
    NEUROBIOLOGY OF AGING, 2012, 33 : S37 - S37
  • [4] Zebrafish Experimental Animal Models for AD: A Comprehensive Review
    Sande, Ruksar
    Godad, Angel
    Doshi, Gaurav
    CURRENT REVIEWS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY, 2024, 19 (04) : 295 - 311
  • [5] Hypothalamic dysfunction and metabolic dysregulation in AD animal models
    da Silva, R. A. Goncalves
    Lyra e Silva, N. de Menezes
    Peny, J. A.
    Lima Filho, R. A.
    Clarke, J. R.
    Munoz, D. P.
    Ferreira, S. T.
    Fraser, P.
    De Felice, F. G.
    JOURNAL OF NEUROCHEMISTRY, 2017, 142 : 214 - 214
  • [6] Clinical psychopharmacology of AD/HD: Implications for animal models
    Solanto, MV
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2000, 24 (01): : 27 - 30
  • [7] Predicting ad sales using hybrid models
    Xiao, YQ
    Martin, J
    PROCEEDINGS OF THE 7TH JOINT CONFERENCE ON INFORMATION SCIENCES, 2003, : 455 - 457
  • [8] Effect of AD-5423 on animal models of schizophrenia: phencyclidine-induced behavioral changes in mice
    Nagai, T
    Noda, Y
    Une, T
    Furukawa, K
    Furukawa, H
    Kan, QM
    Nabeshima, T
    NEUROREPORT, 2003, 14 (02) : 269 - 272
  • [9] Navigating in the Dark: Modeling Uncertainty in Ad Hoc Retrieval Using Multiple Relevance Models
    Soskin, Natali
    Kurland, Oren
    Domshlak, Carmel
    ADVANCES IN INFORMATION RETRIEVAL THEORY, 2009, 5766 : 79 - 91
  • [10] IMMUNOTHERAPY TARGETING TAU AND AMYLOID Ab PATHOLOGY IN AD ANIMAL MODELS
    Boutajangout, Allal
    Al-Ahwal, Mahmoud
    Habib, Hamid
    Wisniewski, Thomas
    NEUROBIOLOGY OF AGING, 2014, 35 (03) : 721 - 721